Kairos Pharma KAPA
NYSE KAPA
$0.59 +0.01 (+1.77%)
As of: Oct 22, 2026 · 10:03 AM EDT

Kairos Pharma (KAPA) Intangibles (2023 - 2025)

Updated

Kairos Pharma (KAPA) reported Intangibles of $62,000 for Q4 2025, down 72.1% from $222,000 a year earlier.

Analysis

Kairos Pharma (KAPA) Intangibles (2023 - 2025) Analysis & Trends

Dating back to Q4 2023, Kairos Pharma's Intangibles record includes 6 quarters.

  • By year, Intangibles came in at $222,000 in FY2024 (-41.9%) and $382,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn 18.11 Bn
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn 48.23 Bn
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn 49.14 Bn
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn 24.98 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 42.07 Bn
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn 37.72 Bn
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn 20.49 Bn
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn 14.03 Bn
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn 47.05 Bn
10 Kairos Pharma 10.82 Mn -1.60 Mn - 62,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 62,000.00
Jun 30, 2025 142,000.00
Mar 31, 2025 182,000.00
Dec 31, 2024 222,000.00
Sep 30, 2024 262,000.00
Dec 31, 2023 382,000.00
API Access

Kairos Pharma Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=KAPA&period=max&api_key=YOUR_API_KEY